American General Life Insurance (Corebridge) Review, 2026
Written and reviewed by Hans Goldstein, licensed insurance producer, NPN 20602398 · CA Insurance License #4273294Last reviewed · Published October 3, 2026
Editorial review by a licensed agent who may earn a commission. No insurer pays for placement or grades. Hans is paid a commission by the insurer if you buy a policy through him. For life insurance, ask and he will tell you what he earns on your specific policy.
Who American General is now
If you own an "AIG" or "American General" life policy, your insurer is American General Life Insurance Company (AGL), part of Corebridge Financial, which separated from AIG. New York policies are issued by The United States Life Insurance Company in the City of New York. Your policy terms do not change because of a name change or a corporate merger; the contract stays with the issuing insurer.
Companies: American General Life Insurance Company (AGL); The United States Life Insurance Company in the City of New York
AM Best financial strength: A, placed under review with developing implications 3/27/2026 (pending Equitable merger) (AM Best: Corebridge (AGL) ratings placed under review (3/27/2026)).
Market position: Top 20 in 2025 IUL new premium (LIMRA: 2025 full-year top 20 IUL company rankings).
On the record:
- Merger with Equitable Holdings approved by shareholders 7/30/2026; closing expected by year-end 2026. AM Best ratings under review until it closes. (Jul 30, 2026, source pending)
| Product | Type | Provisional Goldstein Index |
|---|---|---|
| Max Accumulator+ III | IUL | Pending 35% graded |
An honest presentation of anything non-guaranteed uses words like "up to", "could" or "illustrated at". If you hear "will" about cash value, index credits, loan income or a living-benefit payout ("this policy will pay you 80%", "you will have $1 million at 65"), treat it as a red flag. Only the guaranteed column and the contract's stated guarantees are promises; ask the person to show you where the word "guaranteed" appears.
AI voices. Education, not tax or legal advice. Hans is paid a commission if you buy a policy through him. Comment REVIEW on the video for the checklist.
The Equitable merger, and what it means for policyholders
Corebridge's shareholders approved a merger with Equitable Holdings on July 30, 2026, with closing expected by year-end 2026. On March 27, 2026, AM Best placed Corebridge's ratings under review with developing implications, which is the standard step while a large transaction is pending (AM Best). "Developing" means the outcome could move the rating either way once the deal closes. For an existing policy, the practical point is simple: keep paying as planned, and check the rating again after closing. For a new purchase, it is a fair reason to compare, not a reason to panic.
Is your American General policy on track?
Send your email and I'll send the in-force illustration request letter and what to check before and after the merger closes.
We’ll email it to you. Hans Goldstein · NPN 20602398.
Rather talk it through? Or book 15 minutes on Hans’s calendar.
IUL: Max Accumulator+ III and the dollar-for-dollar chronic benefit
Most no-charge living-benefit riders pay a discounted amount at claim, based on life expectancy. Corebridge's Accelerated Access Solution on Max Accumulator+ works differently: it pays dollar for dollar, as 2% or 4% of the death benefit each month, up to $3 million, with no rider fee on that product (Corebridge AAS). That is the strongest living-benefit design among the IULs graded in this pilot.
Goldstein Scorecard: Max Accumulator+ III
Goldstein Scorecard · Goldstein Index v1 · graded Oct 3, 2026 · how we grade →
Corebridge Financial (American General Life) · vs. other indexed universal life policies · Draft grades on public data. Grades are shown on the page only and are Hans's editorial view.
| Dimension (weight) | Grade | One-line take |
|---|---|---|
| Cap / participation strength (15%) | Pending | No current public cap sheet found; Hans to pull the current rate sheet |
| Floor and guaranteed minimums (5%) | Pending | Floor and guaranteed minimums to confirm from the policy form |
| Loan options and current loan rate (15%) | B+ | Standard loan nets 1% (3.00% charged, 2.00% credited); participating loan 5.50% current, 8% max. [1] as of Jun 2026 |
| COI and charge drag (15%) | Pending | Charge schedules are in the policy form and illustration, not public; graded from the standardized case |
| Living-benefit riders (10%) | A | Dollar-for-dollar monthly acceleration with no rider fee on this product, which avoids the deep discounts of present-value riders. [2] as of Oct 3, 2026 |
| Overloan protection (5%) | Pending | No overloan protection rider found in public materials; confirm |
| Illustration conservatism (AG 49-A/B) (10%) | Pending | Graded from the illustrated rate in the standardized case vs peers |
| Carrier strength (10%) | B+ | AM Best A, placed under review with developing implications 3/27/2026 (pending Equitable merger). Watch item until the review resolves. [3] as of Mar 27, 2026 re-grading |
| Cash value at years 10/20 vs peers (standard case) (15%) | Pending | Needs Hans's standardized illustration (WinFlex/iPipeline), on file before grading |
| Guaranteed minimum cap disclosed (disclosure, not weighted) | No | Not publicly disclosed. Ask for it: it is the lowest the cap can ever go. |
| OVERALL | Incomplete | No overall grade yet: only 35% of the Index weight can be graded from public data (those dimensions average A-). The overall grade waits for Hans's standardized case (M45 preferred nonsmoker, $12,000/yr to 65, max-funded Option B to A, plus a minimum-funded case at the same death benefit). |
On public data, Max Accumulator+ III grades strongest on living-benefit riders. 6 of 9 dimensions wait for a standardized illustration, so treat this as a starting point, not a verdict. Neutral summary of the scorecard, not a personal recommendation.
Best for: Accumulation buyers who also want a chronic illness benefit that pays dollar for dollar.
Look elsewhere if: You want to wait until the Equitable merger closes and AM Best resolves its review.
- Ask: what is the guaranteed minimum cap and the guaranteed minimum participation rate in the contract for each index account? Not today's cap, the floor the cap can never go below.
- Why it matters: today's cap is not guaranteed. The insurer can lower caps on your policy over time, all the way down to that contractual minimum. Guaranteed minimum caps we have seen published run from 0.25% to 4% (insurer documents, 2024 to 2026), and several insurers don't publish theirs at all. That is a very different worst case.
- Many agents cannot answer this question on the spot. If yours can't, ask them to find it in the policy form or the illustration's guaranteed assumptions before you sign.
Where the insurer publishes it, the Goldstein Scorecard shows the guaranteed minimum cap; otherwise it says "not publicly disclosed". Caps, participation rates, loan rates, charges and dividends are not guaranteed and can change.
Caps, loan rates and charges for Max Accumulator+ III are not published publicly, so those grades are pending. Ask for an illustration with guaranteed, midpoint and illustrated-scale columns before you buy.
Where the premium goes, and the cost of insurance ladder
In this model a male 45 paying $10,000 a year loses about 15% of the first 10 years of premium to charges when the policy is max-funded, and about 22% when the same premium buys three times the death benefit. The surrender charge is extra: in year 1 the cash surrender value is about $4,245 of $10,000 (max-funded) and $0 (target-funded), which is why early cash value can feel like half the premium disappeared. A common rule of thumb is that roughly half of early premium goes to charges; in this model that is close for year-one surrender value, and too high for the ongoing charges in a well-funded design.
Hypothetical. Not an illustration of any specific policy. Not a quote. Model on current (non-guaranteed) charges: premium load 10% (years 1-10) then 5%, $10 a month fee, per-$1,000 charge for 10 years, current COI at 80% of 2017 CSO select rates, 6% illustrated crediting. Guaranteed maximum charges are higher. Ask your insurer for the policy's actual charge schedule.
Read it like a ladder. The insurance part of the policy gets more expensive every year: the guaranteed maximum rate is about $8 per $1,000 at 65, $24 at 75 and $82 at 85 (2017 CSO). Each step is small until the late 70s, then the ladder curves up sharply. In a well-funded policy the cash value grows faster than the charges, so the policy carries itself with no extra premium (green). In an underfunded policy the charges eat the cash value from the inside, and the owner must pay more or the policy lapses (red, at 79 here). Real results usually land between those lines, which is why an in-force illustration every few years matters.
Hypothetical. Not an illustration of any specific policy. Not a quote. Male 45, preferred nonsmoker. Charges per the stated model; COI is charged on the net amount at risk (death benefit minus cash value), so the dollar cost depends on both the rate and how much coverage the cash value has not yet replaced. Source for rates: Society of Actuaries, 2017 CSO table 3291.
Term: Select-a-Term and conversion
Per an April 2024 industry compilation of conversion privileges (secondary source), Corebridge's Select-a-Term can generally be converted until the earlier of the end of the level period or age 70 (Tritium). Conversion lets you move to permanent coverage without new medical evidence, which is how you lock in today's health. Confirm the exact deadline and the products you can convert to in your own policy, since terms vary by issue year. See term conversion and the deadline checker.
Owners: what to check this year
- Find your policy number and the issuing company on your annual statement (AGL or US Life in New York).
- If you own universal life or IUL, request an in-force illustration showing current and guaranteed values to age 100 (template on the policy review page).
- If you own Select-a-Term, write down your conversion deadline.
- After the Equitable merger closes, check the updated AM Best rating.
Who Corebridge fits
Corebridge fits accumulation buyers who also want a chronic illness benefit that pays close to full value, and term buyers who want a long conversion window. If you would rather wait until the merger closes and AM Best resolves its review, compare other IULs by buyer type in the meantime.
Own a Corebridge or American General policy?
Send the statement or in-force illustration. Within one business day you get a written read: is it on track, what the merger means for you, and whether anything should change.
Rather talk it through? Or book 15 minutes on Hans’s calendar, or call 213-414-2808.
Hans Goldstein · 213-414-2808 · NPN 20602398, independent licensed insurance producer
Frequently asked questions
Sources
- AM Best: Corebridge (AGL) ratings placed under review (3/27/2026)
- Corebridge: Accelerated Access Solution (AGLC109731)
- LIMRA: 2025 full-year top 20 IUL company rankings
- Tritium: term conversion privileges by carrier (April 2024 compilation)
Hans Goldstein, CA Insurance License #4273294 · NPN 20602398 · Goldstein & Co. LLC dba Goldstein Insurance Services, CA License #6016830
Contact: hans@hansgoldstein.com · 213-414-2808
General education, not tax or legal advice. Tax treatment depends on your facts and on current law, which can change. Talk to your CPA or estate attorney. Guarantees are backed by the financial strength and claims-paying ability of the issuing insurance company. Guarantees apply only to the contractual terms of the policy. Caps, participation rates, loan rates, charges and dividends are not guaranteed and can change. Hans is paid a commission by the insurer if you buy a policy through him. For life insurance, ask and he will tell you what he earns on your specific policy. Product and company names are trademarks of their owners. Goldstein Insurance Services is an independent agency, not affiliated with or endorsed by any insurer named here. Life insurance requires underwriting; not everyone qualifies. This page describes products in general terms; read the policy and the insurer's disclosures before you buy.